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ABSTRACT
Pre-diabetes and diabetes occur secondary to a
constellation of pathophysiological
abnormalities that culminate in insulin
resistance, which results in reduced cellular
glucose uptake and increased glucose
production. Although pre-diabetes and
diabetes have a strong genetic basis, they are
largely environmentally driven through
lifestyle factors. Traditional lifestyle factors
such as diet and physical activity do not fully
explain the dramatic rise in the incidence and
prevalence of diabetes mellitus. Sleep has
emerged as an additional lifestyle behavior,
important for metabolic health and energy
homeostasis. In this article, we review the
current evidence surrounding the
sleep-diabetes association.
Keywords: Circadian misalignment;
Chronotype; Obesity; Sleep quality; Sleep
duration; Type 2 diabetes mellitus
INTRODUCTION
The onset, progression and management of type
2 diabetes mellitus remain a major challenge.
Given the many accompanying complications
and comorbidities of diabetes, a comprehensive
understanding of all factors underpinning its
development and progression is absolutely
essential. A profusion of literature surrounds
the role of sleep and type 2 diabetes. Sleep is a
significant and modifiable lifestyle behavior.
Understanding the relationship between sleep
and diabetes mellitus is crucial and will enable
the development of strategies to improve the
life of those with diabetes.
Sleep is regulated by two interconnected
processes, named Process S (homeostatic drive)
and Process C (circadian drive) [1]. Process S is
appetitive in that a sleep debt occurs
throughout the day and this increases the
pressure to sleep. This sleep debt is repaid
once sleep occurs. If the sleep debt is not
sufficiently repaid, it accumulates, resulting in
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poor daytime function and potentially
metabolic abnormalities. Process S is associated
with central adenosine accumulation. Caffeine
is an adenosine receptor blocker. Therefore,
caffeine intake around bedtime will reduce the
homeostatic drive and reduce sleep duration. If
Process S were the only regulator, then because
of accumulated sleep debt, one would fall asleep
in the early evening. This is prevented by
Process C, which determines the timing of
sleep. Circadian regulation occurs via the
hypothalamic suprachiasmatic nucleus and is
synchronized by light via the
retino-hypothalamic tract. Thus, light
exposure near bedtime delays sleep, and if this
is combined with early morning awakening for
work, then sleep duration is reduced. Many
hormones are released in a circadian manner, a
typical example being cortisol, which is high in
the morning and low in the evening. If Process S
and Process C are desynchronized, as occurs in
jet lag or night shift work, then metabolic
consequences can ensue, secondary to
hormonal alterations. Once sleep occurs,
several hormones are released specifically
linked to sleep stages. For example, growth
hormone and prolactin are released during the
deep stages of sleep. Thus, sleep loss can also
impact the release of hormones that regulate
metabolic function. Sleep is assessed using
several approaches, each with its own
advantages and disadvantages (Table 1).
The aim of this review is to highlight and
discuss the relevant literature surrounding the
relationship between sleep parameters and
diabetes outcomes. Specifically, we provide a
comprehensive review of the literature for
multiple components of sleep (quantity,
quality and timing, circadian misalignment
and daytime sleep) and diabetes outcomes,
which we present according to study design
(case-control, cross-sectional, prospective and
experimental). We further discuss potential
mechanisms, limitations of the current
literature as well as future directions.
Compliance with Ethics Guidelines
This article is based on previously conducted
studies and does not involve any new studies of
human or animal subjects performed by any of
the authors.
Study Selection Criteria
Our review focused on the literature
surrounding multiple sleep features and the
relationship with measures/indicators of type 2
diabetes mellitus. Specifically, we reviewed the
literature for human, adult (C18 years)
populations and excluded animal studies or
studies not published in the English language.
We selected studies using a comprehensive
search of the electronic databases, PubMed
and MEDLINE. The search terms entered into
these electronic databases in May 2015
included: type 2 diabetes mellitus, insulin
resistance, insulin sensitivity, glycemic
control, glucose control and sleep duration,
sleep quality, circadian misalignment, circadian
preference, chronotype and napping. The
search highlighted a total of 83 studies of
which there were 6 case-control, 41
cross-sectional, 15 prospective cohort and 21
experimental studies.
Sleep Quantity, Insulin Resistance
and Diabetes
Sleep curtailment is now widespread, usually to
accommodate busy lifestyles within
contemporary society, mirroring the increases
in global diabetes mellitus [2]. The use of
modern technology is also increasingly
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Table 1 The advantages and limitations of the various methods used to measure sleep
Sleep measure Measure Advantages Limitations
Polysomnography
(PSG)
Objective Accurate for determining multiple sleep
parameters
Expensive
Gold standard Can be used to diagnose sleep disorders Experienced/trained technicians are
needed to score the data
Physiological Can be combined with other
physiological measures (hormone
sampling under controlled conditions)
May not be able to capture usual sleep
because of equipment and/or
environment (ﬁrst night effect)
Determines sleep architecture (sleep




(stages 1, 2, 3
and REM
sleep)
Measures brain activity as well as other
physiological outcomes (muscle
relaxation, eye movements respiratory
effort and more)
Unsuitable for long-term sleep





Objective measure of sleep-wake timings Cannot determine sleep architecture
(sleep stages)
Can be used in the individual’s natural
environment in free-living conditions
Provides an estimate of sleep-wake
timings
Worn on wrist Some devices have been validated for
sleep duration against PSG
Some devices are not waterproof and




Ability to collect data over prolonged
periods of time (up to 3 consecutive
months)
Absence of physiological measures to
determine sleep
Cost-effective alternative to PSG Requires concurrent sleep diary and
minimum wear time
Noninvasive May over estimate sleep during periods
of inactivity




Objective Not validated against PSG for sleep
Additional physiological measures are
obtained (heart rate) for sleep
determination
Loss of signal if skin contact is poor or
the ECG pads become loose/removed
Diabetes Ther (2015) 6:425–468 427
Table 1 continued
Sleep measure Measure Advantages Limitations
Physiological Can be used in free-living conditions and
natural environments
Does not have the ability to determine
sleep architecture (sleep staging)
Can collect data over prolonged periods
of time
Accurate accompanying sleep diary is
usually required
Noninvasive May overestimate sleep during periods
of inactivity
Can be uncomfortable and/or result in





Subjective Can be administered to large populations Subject to a number of biases (recall,
social desirability)
Quick/easy to administer Variable response rates
Cost-effective Subjective
Some are validated in different age groups
to investigate different age-appropriate
sleep problems (pain in the elderly,
bedroom sharing in children)
Inaccurate for detecting sleep disorders
Less labor intensive compared to PSG May be subject to missing data
Some are validated for sleep duration
against objective measures of sleep
May result in time in bed being
reported rather than total sleep time
Can help to ascertain information about
multiple sleep parameters and other
related factors
Information collected may not be





Administration is quick Subject to a number of biases (recall,
social desirability)
Immediate output May have missing data
Permits data collection in large samples
relating to pediatric sleep information
Likely to be inaccurate for older
children and adolescents (parents
may be unaware of night awakenings
and/or other sleep features)
Less labor intensive compared to PSG Variable response rates
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intruding into sleep time. The Sleep Heart
Health Study is an early study that observed,
in a large sample of US men and women, that
short self-reported sleep duration (B5 h per
night) was associated with a 251% increased
odds ratio (OR) of T2DM [3]. Furthermore,
compared to those with sleep duration of
7–8 h, those with sleep duration of C9 h had a
79% increased odds of T2DM and an 88%
increased odds of pre-diabetes. This early study
adjusted for age, gender, ethnicity, the apnea
hypopnea index (AHI), study recruitment site,
and waist circumference as potential
confounders, although data on primary drivers
of diabetes (physical activity, dietary habits,
family history) were not included in the
analyses [3]. Further evidence has resulted
from a small number of case-control studies
that are highlighted in Table 2.
Cross-Sectional Studies
The cross-sectional evidence linking sleep
duration to T2DM has continued to
accumulate (Table 3). The majority of studies
have indicated an increased possibility of
various diabetes outcomes with differing
definitions of short sleep duration [4–17].
Understanding pre-diabetes provides a key
insight into the development of T2DM.
Chaput and colleagues performed an oral
glucose tolerance test in 740 participants, aged
21–64 years without a known diabetes
diagnosis. Sleep duration (h) was self-reported
from only one question, inserted into a
self-administered physical activity
questionnaire. After adjustment for major
confounders such as physical activity and
energy intake (self-reported) along with age,
marital and employment status, education,
Table 1 continued
Sleep measure Measure Advantages Limitations
May result in time in bed being
reported rather than total sleep time,
thus overestimating sleep causing
inaccuracies
Sleep/time diary Subjective Obtains prospective sleep-wake data Completion is tedious
Provides additional information about
other sleep features (time in bed, sleep
duration, night awakenings, napping,
sleep quality)
Response rates may be low or diaries
may be only partially completed
(missing data)
Inexpensive Subjective
Permits data collection in large samples Labor intensive for the participant
Less labor intensive compared to PSG Requires participants to be motivated
to complete
Swift administration Subject to inaccuracies/biases (recall,
social desirability)
REM rapid eye movement, PSG polysomnography
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household income, alcohol and coffee
consumption, hypertension and heart disease,
the OR for insulin resistance, determined using
the homeostasis model assessment (HOMA-IR),
for men and women reporting short sleep
duration (5–6 h per night) was 2.27 and 1.82,
respectively (both p\0.05). Long sleep
duration (9–10 h per night) was also
significantly associated with pre-diabetes in
both men and women, but with smaller ORs
of 1.51 and 1.67, respectively [4]. While this
study included many potential confounders
and benefited from a relatively large sample, a
major concern is the limited subjective sleep
information.
To overcome the issue of subjective sleep
reports, Vgontzas and colleagues employed
polysomnography (PSG; the gold-standard
sleep measure) to investigate the relationship
between sleep and T2DM. A fasted blood
glucose sample was obtained the morning
after 1 night’s PSG had been conducted to
screen participants for sleep-disordered
breathing (SDB), known to be closely
associated with T2DM. Severe short sleep
duration (B5 h) was significantly associated
with a 2.95 times odds of T2DM [18]. While
the authors adjusted for a range of potential
confounders including age, race, sex, BMI,
sampling weight, smoking, alcohol, depression
and SDB, the two major lifestyle drivers (diet
and physical activity) and family history of
diabetes were unaccounted for. Investigating
sleep in those susceptible to diabetes has
provided key information regarding the
sleep-diabetes relationship. Darukhanavala
et al. studied 47 at-risk participants with a
family history of diabetes but who were
otherwise healthy and monitored them with
wrist actigraphy for 14 consecutive days/nights.
Insulin sensitivity was determined using
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Table 3 Cross-sectional studies investigating the association between sleep features and diabetes outcomes
First author
(year)















































































































































































































































































































PSQI Physician diagnosis of
T2DM for at least
1y and taking oral
medication
55% of the sample
had poor sleep
quality

































PSQI HbA1c from blood
draw
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IGT and lack of
sleep OR 2.3*
for men only
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was observed between actigraphy-estimated
sleep duration and insulin sensitivity (b = 2.5,
p = 0.006), after adjustment of major
confounders such as physical activity and
diabetes family history [19].
Currently, there are no cross-sectional
studies that have objectively investigated the
sleep-diabetes link while adjusting for the three
key drivers of diabetes (energy intake, energy
expenditure and diabetes family history). The
issue with obtaining data from populations
with existing diabetes comorbidities, such as
SDB, is that sleep insufficiency may be a result
of the condition itself, which may have already
driven physiological alterations. Thus,
case-control (Table 3) and prospective studies
provide key evidence for unraveling this and
clarifying temporal associations.
Prospective Studies
A summary of prospective studies that have
examined the sleep-diabetes relationship can be
found in Table 4. The Niigata Wellness Study,
which prospectively studied 38,987 Japanese
participants without diabetes over an 8-year
period, found that younger individuals
(\60 years old) who reported sleeping \5.5 h
per night had a 53% significant increased risk of
developing diabetes compared to those that
slept for 7–7.5 h per night, after adjustment
[20]. Gangwisch and colleagues reported a
similar significant risk for incident diabetes
with short sleep. Participants, aged 32–86 years
(n = 8992), recruited into the National Health
and Nutrition Examination Survey were
examined over a 10-year period. Short sleep
duration was defined as B5 h and was associated
with 1.47 increased odds of incident diabetes
[21]. Other prospective data suggest similar
effect sizes but vary according to adjustment
of confounders and short sleep duration
definition [22, 23]. The prospective evidence
is, however, less consistent with some reporting














HOMA-IR OR 3.26* for those
with short sleep







OGTT oral glucose tolerance test, T2DM type 2 diabetes mellitus, IGT impaired glucose tolerance, ADA American Diabetes
Association, WHO World Health Organization, AHI apnea hypopnea index, OR odds ratio, OSA obstructive sleep apnea,
BMI body mass index, WC waist circumference, BF% body fat percent, HOMA-IR homeostasis model assessment-insulin
resistance, PSQI Pittsburgh Sleep Quality Index, PSG polysomnography, HDL-C high density lipoprotein-cholesterol,
LDL-C low high density lipoprotein-cholesterol, IFG impaired fasting glucose, FPG fasting plasma glucose, RDI respiratory
disposition index, ESS Epworth Sleepiness Scale,MEQ morningness-eveningness questionnaire, IVGTT intravenous glucose
tolerance test
* p\0.05
442 Diabetes Ther (2015) 6:425–468
BMI [24]. Furthermore, at least one study has
reported an increased risk for incident diabetes
in long sleepers by more than three-fold [25].
The longitudinal data are less convincing than
the cross-sectional evidence with several
prospective studies indicating no association
between sleep duration and incident diabetes
[26–28]. Further prospective data are necessary
to determine cause-effect associations, and
while the majority of studies benefit from
large samples, including both genders and
incorporating different ethnic backgrounds,
the lack of objective sleep data is a significant
limitation [20–30]. Also, the majority of
prospective studies assessing sleep duration
and diabetes outcomes have focused on
incident diabetes, with few investigating sleep
with pre-diabetes [29, 30]. Both studies,
however, documented similar effect sizes that
were statistically significant for short sleep
duration (albeit with different definitions and
varied adjustments). Uncertainty from
prospective data has been somewhat offset by
evidence from experimental studies.
Experimental sleep manipulation in a
controlled laboratory environment has shown
a consistent relationship between sleep
duration and diabetes outcomes.
Experimental Studies
Increasing numbers of experimental sleep
studies (summarized in Table 5) have explored
the association between sleep and diabetes
using objective measures to confront the
problems associated with subjective sleep. One
of the earliest experimental sleep studies to
examine the effects of sleep upon glucose
metabolism recruited healthy, young, male
volunteers (n = 11) for 16 consecutive nights
of laboratory attendance [31]. Participants spent
3 nights of 8 h time in bed (TIB) for baseline
assessment, followed by 6 nights of sleep
restriction with 4 h TIB and finally 7 nights of
sleep recovery with 12 h TIB. PSG was used to
monitor sleep outcomes on the last nights of
each of the three conditions and blood
sampling performed at the end of the sleep
restriction and sleep recovery conditions to
assess multiple hormones and carbohydrate
metabolism. An intravenous glucose tolerance
test (IVGTT) and breakfast meal response were
performed to investigate insulin sensitivity and
glucose effectiveness. Findings from the study
indicated a 40% reduced glucose clearance after
the IVGTT following sleep restriction compared
to sleep recovery. The insulin response to
glucose was reduced by 30% after sleep
restriction, an early indicator of diabetes.
Furthermore, glucose effectiveness, which is
independent of insulin, was significantly
reduced by 30% after sleep loss versus sleep
recovery [31].
To overcome several issues including the
potential confounding effect of the presence of
diabetes-related comorbidities as well as
laboratory attendance and extreme sleep
restriction, Zielinski et al. studied 40 healthy
individuals (aged 50–70 years) utilizing
continuous wrist actigraphy monitoring for
10 weeks [32]. Two weeks of baseline sleep was
acquired for determination of habitual sleep
habits/duration, and volunteers were
subsequently randomized into one of two
conditions: (1) 90-min TIB reduction,
compared to the pre-determined baseline
median TIB, with fixed bedtimes for 8
consecutive weeks (n = 22), or (2) control
condition with fixed bedtimes, matching the
baseline TIB (n = 18). An oral glucose tolerance
test was conducted to determine glucose and
glucose tolerance; insulin sensitivity was
assessed using the quantitative
insulin-sensitivity check index. The results
were not consistent with the findings from
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Spiegel and colleagues [31]. No significant
associations were discovered between sleep
condition and insulin resistance. There are
various explanations, possibly from differences
between study protocols, that may account for
these observed discrepancies. First, volunteers
were permitted to increase caffeine intake
during sleep restriction to promote
wakefulness [32]. Second, sleep restriction
strategies were discussed between the
volunteer and researcher to ensure facilitation,
which may have resulted in different
approaches to different individuals according
to circadian preference that were not obtained
and therefore not adjusted for within the
analyses [32]. Third, a number of individuals
completed the OGTT 2–5 days after the end of
the 8-week manipulation [32]. These volunteers
were instructed to continue with the allocated
TIB until the OGTT had been performed, but
reporting on continued compliance was not
documented and may have biased the findings.
Furthermore, extended time periods beyond the
experimental period may have resulted in
differences, although comparisons were not
made in the analyses for these subjects.
Fourth, a reduction of 90 min in Zielinski’s
protocol [32] may be inadequate to observe a
significant effect and is less extreme than
Spiegel’s 4-h TIB [31]. Finally, the study
recruited older individuals with a prolonged
amount of TIB (9 h) versus total sleep time
(7.4 h) [32], as compared to young healthy men
in Spiegel’s study [31].
Recent detailed study of hepatic and
peripheral insulin sensitivity, as well as
substrate utilization, in response to sleep
restriction has been investigated. Rao and
colleagues have revealed that an acute bout of
extreme sleep reduction can result in profound
metabolic alterations [33]. Participants received
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by two conditions in a randomized crossover
approach undertaking 5 nights of sleep
restriction (4 h TIB) and normal sleep (8 h
TIB), monitored using ambulatory PSG. At the
end of the 5-night sleep restriction period,
peripheral and whole-body insulin sensitivity
significantly decreased by 29% and 25%,
respectively. No changes were noted for
hepatic insulin sensitivity using the
gold-standard hyperinsulinemic-euglycemic
clamp technique [33]. An OGTT was also
administered and HOMA-IR calculated, which
revealed a 20% increase in insulin secretion
following sleep restriction [33]. The authors of
other experimental studies have reported
comparable findings [34–37]. Similar effect
sizes have also been reported following just 1
night of sleep reduction (4-h TIB) [38],
suggesting that acute, extreme sleep restriction
may result in metabolic disruption and a
predisposition to diabetes.
The advantages of experimental sleep studies
are that they usually benefit from the
gold-standard measure to monitor sleep and
incorporate accurate diabetes outcomes under
very tightly controlled conditions, thereby
removing the effect of known confounders.
However, laboratory attendance may interfere
with the natural sleep patterns and/or
architecture, thereby introducing potential
biases including environmental change (room
temperature, altered noise/lighting, different
bed comfort and more) and equipment to
monitor sleep and diabetes (PSG wiring,
catheters for repeated blood sampling). While
laboratory studies are usually conducted under
strictly controlled conditions, this may alter
naturally occurring behaviors during
attendance and objectively determined
retrospective aspects of participant lifestyles
and/or previous related events may not be
considered but are crucial and may influence
the findings. Furthermore, extreme sleep
restriction is usually enforced but is not
representative of voluntary small amounts of
sleep loss experienced in societal behaviors.
Finally, the majority of experimental work has
been performed in healthy, young and male
participants; therefore, the findings may not
extend to other groups. That said, results of
experimental sleep studies coupled with
findings from large observational studies
suggest a definitive association between sleep
loss and diabetes. PSG monitoring confirms
adherence to sleep manipulation by
determining the total sleep time, but the
authors do not usually report on other sleep
features, despite the availability of output.
Although the majority have focused on sleep
duration and/or sleep loss, other sleep
characteristics have also emerged to be
important.
Sleep Quality in Relation to Insulin
Resistance and Diabetes
Severely short sleep, defined by some as B5 h
per night, as well as insomnia has been
previously linked to a significantly increased
risk of T2DM [18] and increased insulin
resistance [39] through validated sleep
measures. Lack of self-reported sleep [40] as
well as sleep debt [41] has also been linked to
the condition. These sleep outcomes (insomnia,
lack of sleep and sleep debt) may be due to
poor-quality sleep, which has resulted in
researchers investigating this in relation to
diabetes.
The most commonly used validated sleep
quality questionnaire is the Pittsburgh Sleep
Quality Index (PSQI). It is 24-item survey with 7
subcategories (sleep duration, disturbance,
medication, latency, quality and efficiency as
well as daytime dysfunction) that can be totaled
454 Diabetes Ther (2015) 6:425–468
to provide an overall score [42]. A combined
score of more than five is suggestive of poor
sleep quality. Some have investigated the
prevalence of sleep quality, as determined by
the PSQI, among T2DM. Fiorentini and
colleagues reported a higher prevalence of
T2DM in those with poor-quality sleep
(19.4%) compared to those with good quality
sleep (8.8%) [43]. Similarly, another study
reported 33.3% of 50 participants with an
HbA1c level of [7% had poor quality sleep
[44]. Another reported 55% of 300 T2DM
patients had poor-quality sleep [45]. Further, a
sample of 551 patients in China revealed that
the prevalence of poor sleep quality was
significantly greater in those with poorer
glycemic control and that average insulin
resistance was higher among those with poorer
sleep quality [16]. A larger effect size was
observed by Tsai et al. using HbA1c levels to
compare sleep quality using the PSQI [46]. After
adjustment for age, gender and BMI in a sample
of 46 T2DM patients, poor sleep quality was
associated with poorer glycemic control OR
6.94, p = 0.002 [46]. Small studies with
subjective sleep quality measures may be the
result of chronic complications or ‘side effects’
of T2DM. In an attempt to disentangle the
chronic impact of diabetes on sleep, Rajendran
and colleagues administered the PSQI to
investigate the relationship between sleep
quality and duration of T2DM in 120 patients.
Diabetes duration was negatively associated
with the global PSQI score (b = -020,
p = 0.02), independent of age, gender, BMI,
HbA1c and medication [47]. This association is
consistent with another larger study (n = 614
older patients with T2DM) [48].
Aside from the existing data from diabetic
populations, the relationship between sleep
quality and insulin resistance has also been
investigated in healthy individuals as well as
those at risk of developing T2DM. Hung et al.
examined 1805 participants, of whom 1217 had
normal glucose tolerance (healthy) and 118 had
impaired fasting glucose (IFG), impaired glucose
tolerance (IGT) was present in 287, a total of 80
had both IFG and IGT, and 103 had newly
diagnosed T2DM [49]. Comparisons among
these groups were made according to sleep
quality using the PSQI. The IGT group,
compared to the healthy group, was positively
associated with global PSQI when assessed
through linear regression after adjustment for
a range of confounders including self-reported
physical activity, BMI, demographics, lipids,
blood pressure and lifestyle factors, b = 0.63
(95% CI 0.33–0.94). A similar observation was
reported for individuals with IFG and IGT,
compared to the healthy group, where
b = 0.61 (95% CI 0.06–1.15). The greatest
effect size for poorer sleep quality was present
in those with T2DM versus healthy individuals,
b = 0.86 (95% CI 0.37–1.35). PSQI was then
dichotomized into poor quality ([5) and good
quality (B5) was used as the referent category.
Comparing all groups to the healthy group,
only those with an existing diagnosis of T2DM
showed a significant effect of poor sleep quality,
OR 2.27 (95% CI 1.39–3.70), after adjustment
[49]. Although cross sectional, this study partly
controls for the potential chronic and
psychological impact of diabetes on sleep
given that those with diabetes were unaware
of their diagnosis.
A broad range of characteristics can be used
to measure sleep quality. Sleep efficiency, sleep
fragmentation, number of wake episodes, wake
after sleep onset and length of awakenings are
all indicators. Sleep efficiency (the percentage of
time spent in bed sleeping) has been used to
explore the relationship with diabetes. The
Coronary Artery Risk Development in young
Adults (CARDIA) study recruited young
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individuals (aged 18–30 years) with (n = 40) and
without (n = 115) T2DM [39]. A fasting blood
sample was drawn, and insulin resistance was
measured using HOMA-IR. A wrist actigraphy
device was worn for 3 consecutive days/nights
and repeated around 2 years later to estimate
sleep fragmentation, an indicator of sleep
quality. Insulin resistance was positively and
significantly associated with sleep
fragmentation in those with T2DM only before
and after adjustment, where b = 0.36, p\0.001
and b = 0.35, p\0.001, respectively. Insomnia,
but not sleep duration, was positively associated
with insulin resistance in those with T2DM but
not those without [39]. The relationship
between sleep fragmentation and insulin
sensitivity has been confirmed by others in
case-control studies [50, 51] as well as
experimental manipulation [52]. Two nights of
induced sleep fragmentation in controlled
laboratory conditions has been shown to
significantly decrease insulin sensitivity by
25.2% and glucose effectiveness by 20.9% [52].
Sleep fragmentation is a common feature of
sleep-disordered breathing (SDB), specifically
obstructive sleep apnea (OSA), a condition
closely linked to T2DM (for brief discussion,
see the section titled ‘‘The role of other sleep
features upon insulin resistance and diabetes’’).
The majority of studies highlighting a
relationship between indicators of sleep
quality and diabetes are based on
cross-sectional data [10, 16, 39, 41, 43–49,
53–57], and while just one found no
association [56], causality remains the main
issue. A small number of case-control studies
have aided comparisons of differences in sleep
quality between those with and without T2DM
[50, 51, 58]. There are, however, limited
convincing prospective data. Early work by
Nilsson et al. used a non-validated
questionnaire (two questions) to determine
the difficulty of initiating sleep and use of
hypnotics along with subjectively reported
T2DM with a mean follow-up of 15 years,
reporting a 52% and 78% increased risk of
incident T2DM in those with one or both sleep
features, respectively [59]. Similar findings have
been reported by those with difficulty
maintaining sleep [53]. Conversely, another
group found no association between
difficulties initiating sleep and objectively
confirmed incident T2DM [26]. Thus,
recruitment of initially healthy, young
populations incorporating regular prospective
follow-ups paired with objective sleep/activity
monitoring in the natural environment is
required to confirm or refute the relationship
between sleep quality and diabetes.
The Emerging Effect of Sleep-Wake
Misalignment Upon Insulin Resistance
and Diabetes
While the majority of focus has been on sleep
quantity and quality relative to diabetes, there
is now emerging evidence suggesting that
circadian rhythms, chronotype and sleep-wake
timings play an important role in diabetes
onset, development and management. It is
well established that shift workers have a
higher prevalence of metabolic disorders [60].
In particular, night-shift workers and rotating
shift workers are among those worst affected as
they not only experience circadian disruption
but also sleep loss. These extreme patterns are in
conflict with human evolution and challenge
our internal circadian pacemakers, regulated by
the hypothalamic suprachiasmatic nucleus.
Recent evidence suggests that extreme
sleep-wake timings are not necessary to cause
metabolic alteration, but that even slightly
shifted changes and/or circadian preferences
can influence diabetes.
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Buxton and colleagues examined the effects
of sleep restriction combined with gradual
circadian misalignment (eventually simulating
shift-work patterns) upon glucose metabolism.
A total of 21 healthy participants were
examined across a 39 consecutive day/night
period in a strictly controlled laboratory setting
[61]. A 32% reduction in insulin response to a
standardized meal was reported, resulting in
inadequate glucose regulation. The resting
metabolic rate was also reduced following
experimental manipulation of sleep restriction
and circadian desynchrony, although levels
reverted back to baseline subsequent to 9 days/
nights of recovery sleep [61].
Leproult et al. examined a healthy
population of young (21–39 years) individuals
(n = 26). Wrist actigraphy was used to monitor
standardized sleep-wake schedules 1 week prior
to the circadian misalignment intervention
[36]. Upon laboratory attendance, sleep was
monitored using PSG and volunteers underwent
3 baseline days/nights, then 8 days/nights of 5 h
TIB (centered around 03:00: circadian
alignment). Half of the sample experienced an
8.5-h delay in bedtimes (09:00–14:00) for 4 of
the 8 nights (circadian misalignment), followed
by 3 nights of sleep recovery. All participants
encountered the same amount of sleep
opportunity (24 h over 8 days/nights),
ensuring the effect of circadian misalignment
per se was examined. An IVGTT was performed
following an overnight fast on the 2nd baseline
day as well as on the 2nd to last day of the
intervention, and multiple blood samples were
obtained. Insulin sensitivity was decreased in
96% of the sample, which was unaccompanied
by an increase in responsiveness of b-cell
function. The decrease in insulin sensitivity
was almost double in the misaligned group
(-58%) versus the controls (-32%), p = 0.011.
Similarly, a greater effect was observed in the
experimental group where C-reactive protein
(an indicator of systemic inflammation)
increased by 146% from baseline compared to
the control group (?64%).
Taken together, findings from enforced
circadian misalignment concurrent with sleep
loss provide clues about metabolic alterations
that arise from sleep changes, which challenge
human physiology. It is well known that
physical activity is crucial for preventing
diabetes onset and progression. If sleep loss
paired with circadian misalignment results in
decreases in basal metabolic rate then a greater
amount of energy expenditure will be required
for energy homeostasis. Additional energy
expenditure is less likely when in a
sleep-deprived state. Furthermore, sleep-wake
timings that are inconsistent with human
evolution may result in decreased insulin
sensitivity as well as increased systemic
inflammation, which is associated with
cardiovascular disease. Forced
desynchronization is extreme and simulates
shift work but is not necessarily representative
of societal behaviors or day workers. Other
groups have investigated less radical
approaches of circadian misalignment by
examining circadian preferences
(morningness-eveningness). A number of
studies have investigated circadian preference
in T2DM patients with cross-sectional data [12,
62–65].
One group highlighted a significant
association between HbA1c and self-reported
circadian preference, where b = -1.54, p = 0.03
after adjustment for age and high-density
lipoprotein cholesterol in 101 Japanese men
[65]. Lower scores on the
morningness-eveningness questionnaire (MEQ)
indicate evening types, suggesting that ‘night
owls’ had poorer glycemic control [65]. Another
study included 725 Japanese mixed-gender
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T2DM patients and found a dose-dependent
effect of circadian preference on HbA1c levels.
HbA1c was significantly higher in those with
evening preference (7.3%) compared to
morning types (6.7%), and linear regression
revealed b = -2.94, p\0.01 after adjustment
for a range of established potential confounders
including physical activity, dietary intake and
demographics [64]. One further study that
recruited a random sample of 6,258 Finnish
adults, aged 25–74 years, revealed that evening
types (determined from MEQ) predicted
increased odds of T2DM (OR 2.6, p\0.0001),
after adjustment [12]. Two more studies by the
same group, and possibly data analysis from the
same sample, demonstrated significant evening
chronotype associations with diabetes [62, 63].
A total of 194 T2DM patients were assessed
using the midpoint of sleep, calculated from
self-reported estimated sleep-wake times in
order to determine circadian preference
(chronotype). Glycemic control (HbA1c) was
obtained from medical records, and the
relationship was assessed with circadian
preference. The midpoint of sleep on free days
was positively correlated (r = 0.34, p\0.001)
with glycemic control. In hierarchial regression
analysis, the association remained, where
b = 0.03, p = 0.001 after adjustment [63].
Similar findings were reported in the other
study where it was proposed that chronotype
mediated the association between skipping
breakfast and glycemic control [62].
Aside from experimental work, insulin
sensitivity in relation to circadian
misalignment/preference has not been
extensively examined, although it is a growing
area of study. The existing evidence indicates
that extreme misalignment of sleep-wake
timings in healthy individuals may promote
pre-diabetes. Furthermore, evening types with
T2DM may have poorer glycemic control,
although causality remains undetermined, and
further investigation is required for
confirmation.
The Role of Other Sleep Features Upon
Insulin Resistance and Diabetes
When sleep occurs, highly complex
physiological processes ensue including
hormone release, information processing,
cellular restoration and more. Previously, sleep
was believed to be a phenomenon for and by
the brain. Undoubtedly, the brain regulates
sleep, but evidence now indicates clear
peripheral effects on metabolic outcomes. This
is representative of gradual sleep alterations that
have occurred within contemporary society,
concomitant with the rising prevalence of
metabolic diseases. Much of the research focus
has been on sleep quantity; however, there are
many other significant sleep characteristics that
have been liked to T2DM.
Frequent and longer daytime sleep (napping/
siesta) has been linked to a higher risk of T2DM
prevalence/incidence [66–68]. It has been
suggested that napping may be a consequence
of poor sleep quality and/or insufficient sleep
duration. In the studied populations, however,
napping is habitual and believed to have
beneficial health effects. Napping after lunch
reflects the human circadian rhythm
(post-lunch dip) although, according to the
two-process model of sleep [1], there is
insufficient prior wakefulness to warrant sleep
initiation. Some have therefore considered
daytime napping and combined this with
nocturnal sleep duration (calculating total
sleep time) to investigate the relationship
between total sleep and metabolic outcomes
[69, 70]. Experimental sleep studies, however,
usually prohibit napping in study protocols and
thus may not capture crucial information.
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There are many documented metabolic
consequences of daytime sleep/circadian
misalignment [36, 61, 71], with some linking
this to diabetes complications [72]. Sleep debt is
usually accumulated across the week and repaid
during weekends. Recent experimental data in
19 healthy males with at least a 6-month
history of voluntary sleep curtailment were
recruited. When ‘catch-up’ sleep was not
permitted and short sleep persisted across a
7-day period for 3 weeks, insulin sensitivity
decreased and HOMA-IR increased compared
to those with compensatory weekend catch-up
sleep [73].
Snoring may also be a risk factor for T2DM
[74], possibly as a consequence of OSA.
Undoubtedly, OSA is strongly linked to
diabetes, although which develops first is to be
determined, given that they are both
noncommunicable. Obstructive sleep apnea
(OSA), as well as concomitant intermittent
nocturnal hypoxemia, is common in patients
with T2DM [75, 76]. Several studies have
reported an association between OSA, glycemic
control and diabetes microvascular
complications [77–81]. OSA appears to be
more common in ethnicities where T2DM is
more common [82]. Many studies have not
been able to address the confounding effect of
OSA in the relationship between sleep and
metabolism. Interestingly, continuous positive
airway pressure (CPAP), used to treat OSA, has
also been shown to improve glycemic control
prospectively [75]. Thus, improving sleep can in
turn improve metabolic profiles. While SDB
certainly disrupts metabolic regulation and
extensive data have recently emerged in
relation to insulin resistance and other
features of diabetes, this is beyond the scope
of the current review. Clearly, the extent of
other sleep aspects on metabolic health is
slowly emerging, although a better
understanding of all characteristics is still
required, along with mechanistic explanations.
Significant changes in sleep architecture
have also been noted in a retrospective
case-control study [58]. T2DM patients had
4.5% less slow wave sleep (SWS) and 10.3%
more rapid eye movement (REM) sleep
compared to those without the condition.
Differences in sleep architecture between those
with and without diabetes have also been
investigated in the Sleep Heart Healthy Study
but detected different results [83]. Differences in
SWS between diabetic and non-diabetic
volunteers diminished after adjustment, and
REM sleep accounted for a significantly reduced
proportion of total sleep time in those with
diabetes [83]. Tasali and colleagues attempted to
disentangle this relationship by suppressing
SWS for 3 consecutive nights using an acoustic
stimulus in nine healthy, young volunteers
[84]. SWS suppression was achieved and
resulted in significant reductions in insulin
sensitivity (*25%) and glucose tolerance
(*23%) compared to baseline. SWS is
considered to have a restorative effect; thus, a
reduction in this deep phase of sleep may
induce metabolic alterations that can promote
diabetes as well as other related comorbidities.
SWS declines with age and diabetes risk
increases with age; thus, age may mediate this
relationship, and future studies need to
investigate the strength of such associations in
older individuals as well as those with T2DM.
Mechanisms
There is now clear evidence linking sleep to the
onset and development of pre-diabetes and
T2DM. Understanding the mechanisms
involved is of great importance. It has been
suggested that insufficient sleep and/or poor
quality sleep can result in oxidative stress as
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well as overactivation of the sympathetic
nervous system, and some have used heart rate
variability to support this notion [31]. Others
have shown that changes in the
appetite-regulating hormones leptin (related to
satiety) and ghrelin (related to hunger) have
been observed in response to short/insufficient
sleep duration [85, 86]. Disruption of the
regulation of these hormones from sleep loss
has also been linked to an increased appetite for
carbohydrate-dense foods [85, 86] and intake of
calories from sweet foods (snacks) [87]. Poor
dietary habits are well known to promote
T2DM; thus, the effects of sleep loss may
contribute to these unhealthy behaviors
through metabolic disruption. Sleep
deprivation is associated with activation of the
hypothalamic orexin (hypocretin)
neuropeptide system [88–90]. Orexin
(hypocretin) neurons are located in the lateral
hypothalamus and project throughout the
central nervous system and particularly to
areas important in wakefulness. Orexin
activation is associated with increased
sympathetic nervous system activation,
increased cortisol and suppressed growth
hormone secretion, which can all predispose
to hyperglycemia. Orexin receptor antagonists
are currently under investigation for use in
insomnia, and it would be of interest to study
their impact on metabolism. The importance of
the central nervous system in the regulation of
glucose metabolism has been further
highlighted by the use of bromocriptine in the
treatment of T2DM. Bromocriptine is a
dopamine D2 receptor agonist, primarily used
in the treatment of prolactinoma.
Bromocriptine has received United States Food
and Drug administration approval for the
treatment of T2DM. Its use is supported by
more recent randomized controlled trials
(RCTs) in those with diabetes [91, 92]. The
precise site of action of bromocriptine in
regulating metabolism is unknown, but
dopamine acts at several levels including the
hypothalamus and pineal gland [93], which are
key areas for the regulation of circadian
rhythms, sleep and metabolism. The timing of
bromocriptine administration in glycemic
regulation appears to be important with
greater effects in the morning when
endogenous dopaminergic drive is at its peak.
A side effect of bromocriptine for diabetes
treatment is sleepiness. Dopamine receptor
antagonism by anti-psychotic drugs has been
observed to be associated with obesity and
subsequent insulin resistance and diabetes.
Key Limitations
Some observational data highlight a U-shaped
relationship between sleep and diabetes
prevalence, and while much of the focus has
been on short sleepers, long sleep may also be
problematic and has shown a greater effect size
compared to short sleep in a recent
meta-analysis of prospective studies [94].
Previously, conclusions suggested that long
sleepers possibly have underlying health
issue(s) that result in sleep lengthening. Of
course, this may not always be true; thus, there
is a need to identify general cut points for when
sleep may become harmful, given that sleep
extension studies are underway in an attempt to
address metabolic dysregulation. Definitions of
short/long sleep are also inconsistent, meaning
comparisons can be difficult and conclusions
misconstrued. There is a need for reliable cut
points that can be applied across all studies to
ensure uniformity.
Most of the sleep-diabetes evidence is
consistent although not completely
homogeneous. Of particular concern is the
lack of prospective evidence for sleep quality
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and diabetes onset/progression. Other
prospective discrepancies exist from a powerful
32-year follow-up study [27] finding no
association between sleep and incident
diabetes. There are some potential
explanations for this including (1) the
possibility of OSA as a hidden confounder, an
unrecognized sleep disorder at the time the
study commenced; (2) lack of an objective sleep
measure; (3) gender differences, given that the
study was only conducted in women; (4) dietary
habits were not considered.
Sleep perceptions are subject to several
biases; thus, objective measures in natural
environments are preferable. Participants
should be regularly monitored with validated
wrist actigraphy to ensure sleep-wake
information is captured. However, that said,
sleep is not static, making it incredibly difficult
to capture an accurate picture and study its
effects. Furthermore, there is no gold-standard
measure of dietary intake, an important
confounder of the sleep-diabetes relationship.
Capturing full and accurate information about
food selection, micro-/macronutrients, portion
sizes, methods of cooking, unknown
ingredients in takeaway food and more is near
impossible to reliably measure in a natural
setting. Food diaries are a reasonable
compromise but require specific programs to
analyze the data, are time consuming to
administer, complete and analyze, may not be
completed, are subjective and can therefore
introduce bias. An improved alternative that is
accurate is urgently needed, given that energy
intake/selection can dramatically alter
metabolic regulation and hormone release.
The majority of the work, whether
observational, case-control, prospective or
experimental, has not ascertained or adjusted
for the combination of the three factors known
to promote diabetes (energy intake, energy
expenditure, familial history). This is a major
limitation in the existing literature, and
consistency across studies of all potential
confounding factors is urgently needed.
Studies performed in diabetes patients
usually adjust for diabetes duration and
medications. Details of medications are usually
omitted, but specifications (name, frequency,
dosage and timings) are likely to be important,
particularly for medications shown to alter
sleep. One further consideration is the
possibility of psychological conditions, which
have sometimes been adjusted for in
sleep-diabetes studies. However, medication
related to these conditions, which can
influence sleep-wake behaviors, as well as the
condition itself should be considered.
Commonly used antidepressants, for example,
have significant effects on sleep architecture.
The impact of medications on the sleep-diabetes
relationship can also be complex. For example,
pregabalin enhances sleep by itself and also
reduced sleep disturbance secondary to a
reduction in neuropathic pain in diabetes [95].
In some patients, however, significant weight
gain may occur with pregabalin and other
similar drugs, which increases insulin resistance.
Finally, the majority of the experimental
work has been conducted in young, healthy
individuals, with more data available in men,
given the complexities of the female menstrual
cycle that may interfere with metabolic
hormone measurements. While findings from
these types of studies have highlighted
important information and provided a
foundation for our understanding, detailed
work is required in those with T2DM as well as
older individuals so that we can establish
potential interventions for improving glucose
control in those with long-standing disease or
reverse the condition in those with new
diagnoses.
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Future Directions
Interventions that target those with T2DM, as
well as prevention of its onset, should
incorporate sleep education in addition to
energy balance advice. Emerging evidence
from a small study of healthy volunteers
randomized to sleep extension for 40 days/
nights or control has provided preliminary but
promising results for improving insulin
sensitivity with as little as one additional hour
of time in bed [96]. Future studies should repeat
this sleep extension/improvement of sleep
quality in those with T2DM for further
comprehensive examination and
understanding. After all, making healthy food
selection, controlling portion sizes and
achieving the recommended minimum 30 min
of daily activity require much dedication and
willpower. Conversely, compliance with staying
in bed for an extra hour may be easier and costs
the individual little, but may greatly benefit his
or her metabolic profile and could prevent the
onset and/or progression of diabetes.
The majority of sleep studies in relation to
diabetes mellitus have focused on T2DM. There
is limited information on those with type 1
diabetes, although recent preliminary evidence
has emerged suggesting that multiple sleep
parameters as well as sleep staging play a role
in glycemic control in this population [97, 98].
Sleep may play a key role in other types of
diabetes mellitus although little is known about
this, warranting further investigation.
CONCLUSION
The current evidence suggests that sleep is
instrumental to metabolic regulation and
disease management. Disruption of sleep
homeostasis, which is comprised of multiple
components (quantity, quality, timing and
architecture), can result in adverse metabolic
consequences. The effect of disruption of one
component has been established, but disruption
of multiple sleep features may worsen diabetes
control, although this requires further
investigation. Sleep imbalance may promote
diabetes onset or hinder glucose control and
insulin sensitivity in those with pre-existing
diabetes. Cross-sectional studies as well as
prospective cohort findings demonstrate
reasonably consistent findings and implicate a
role for sleep in the management of diabetes.
Furthermore, acute sleep disruption under
controlled laboratory conditions has shown
significant and negative effects upon glucose
control in healthy adults. Exposure to persistent
sleep imbalance is likely to be detrimental to
metabolic health/disease status. While the
evidence is convincing, a number of
limitations are present, including the
possibility of uncontrolled major confounders,
which restrict robust conclusions. Further
investigation in ‘at risk’ populations as well as
those with T2DM is needed incorporating
objective and prospective sleep measures. It
may be possible to prevent incident diabetes
and smooth the current epidemic by improving
diabetes control through sleep optimization in
combination with other lifestyle advice,
particularly in newly diagnosed cases.
Promoting the importance of sleep for
improving diabetes control/management is
unlikely to result in any harmful
consequences. Awareness of an additional, and
easily modifiable, lifestyle behavior among
healthcare professionals is therefore
recommended.
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